Related Experiment Video
Updated: Jul 9, 2026

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
Published on: October 16, 2018
CD20- and CD56-positive T-cell large granular lymphocyte leukemia in a human T-cell leukemia virus type 1 carrier
Sonoko Nakano-Akamatsu1, Ryoichi Takahashi, Yukiko Sekioka
1Department of Hematology, Omihachiman Community Medical Center, Omihachiman Shiga 523-0082, Japan. naoaki-akamatsu@nifty.com
Insights
This study reports a unique case of T-cell granular lymphocyte (T-LGL) leukemia in a patient who was positive for human T-cell leukemia virus type 1 (HTLV-1). Despite HTLV-1 positivity, the virus did not appear to cause the leukemia.
Area of Science:
- Hematology
- Oncology
- Virology
Background:
- T-cell granular lymphocyte (T-LGL) leukemia is a rare lymphoproliferative disorder.
- Human T-cell leukemia virus type 1 (HTLV-1) is associated with certain hematologic malignancies.
Observation:
- A 60-year-old man presented with asymptomatic T-LGL leukemia.
- The patient was serologically positive for HTLV-1.
- Monoclonal HTLV-1 integration was not detected in peripheral blood.
Findings:
- The neoplastic T-cells exhibited a unique phenotype: CD3+, CD4+, CD8+, CD16-, CD56+, CD57+, TCR alphabeta+, and weak CD20 coexpression.
- HTLV-1 was not implicated in the pathogenesis of T-LGL leukemia in this specific case.
Implications:
- This case highlights the importance of comprehensive phenotypic analysis in T-LGL leukemia.
- It suggests that HTLV-1 seropositivity does not always correlate with viral involvement in T-LGL leukemia pathogenesis.
- Further research may elucidate the complex interplay between viral infections and T-LGL leukemia development.
Abstract:
A 60-year-old man was diagnosed with asymptomatic T-cell granular lymphocyte (T-LGL) leukemia in September 2006. He was serologically positive for human T-cell leukemia virus type 1 (HTLV-1). However, monoclonal integration of the HTLV-1 genome was not detected in the peripheral blood, suggesting that HTLV-1 did not contribute to the pathogenesis of T-LGL leukemia in the present case. Phenotypically, neoplastic cells of our case were CD3+, CD4*, CD8+, CD16-, CD56+, CD57*, and T-cell receptor (TCR) alphabeta+. They also coexpressed CD20 antigen with weak intensity. This represented a unique case of T-LGL leukemia showing a typical clinical and phenotypic features.
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Cytomegalovirus Disease
